Metformina Pharmakern

Metformin, the active ingredient in Metformina Pharmakern, is a Biguanide presented as an oral tablet for oral use. It lowers elevated blood glucose by improving insulin sensitivity and is indicated for the management of type 2 diabetes mellitus in adult patients.

GNH USA supplies Metformina Pharmakern as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for this essential antidiabetic medication. Customers benefit from consistent batch release and comprehensive regulatory support.

Metformin is used to improve glycemic control in disorders related to insulin resistance and hyperglycemia.

Type 2 diabetes mellitus: improves blood glucose levels when combined with diet and exercise Prediabetes (impaired glucose tolerance): may delay progression to type 2 diabetes Polycystic ovary syndrome (PCOS): helps improve insulin sensitivity and menstrual regularity

Metformin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, and loss of appetite - Diarrhea: frequent loose stools, especially during treatment initiation - Metallic taste: transient alteration of taste perception - Weight loss: modest reduction in body weight

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening accumulation of lactate - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis - Hepatic dysfunction: marked elevation of liver enzymes

When prescribing Metformina Pharmakern, clinicians should consider several safety factors to minimize risk. - Renal function: assess eGFR before initiating and monitor periodically - Hepatic disease: avoid in patients with severe liver impairment - Alcohol consumption: limit intake to reduce risk of lactic acidosis - Iodinated contrast procedures: discontinue metformin temporarily before and after imaging - Pregnancy: use only if potential benefit justifies potential risk to fetus - Store at ambient temperature: keep in original container, protect from moisture

Metformin can interact with various medicines, affecting its concentration or increasing adverse effect risk.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and lactic acidosis - Cimetidine: increases metformin plasma levels, raising toxicity risk - Alcohol: excessive intake heightens lactic acidosis potential

Moderate Interactions (Monitor Closely): - Beta‑blockers: can mask hypoglycemia symptoms - Diuretics (especially thiazides): may impair renal clearance of metformin - ACE inhibitors or ARBs: monitor renal function and electrolytes during combined use